Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men

By sjmartinez • March 1, 2024

Krishnan S, Aldana-Bitar J, Golub I, Ichikawa K, Shabir A, Bagheri M, Hamidi H, Benzing T, Kianoush S, Budoff MJ. Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men. Prog Cardiovasc Dis. 2024 Feb 27:S0033-0620(24)00036-7. doi: 10.1016/j.pcad.2024.02.015. Epub ahead of print. PMID: 38423237.

Tags: Aging obesity, Atherosclerosis, Cardiology/Epi, cardiovascular disease, coronary artery calcium, coronary artery disease, Harbor UCLA, Hypogonadism, Non-calcified plaque, Publications, testosterone, Testosterone therapy, TRAVERSE trial

Hepatokine ITIH3 protects against hepatic steatosis by downregulating mitochondrial bioenergetics and de novo lipogenesis

Talari NK, Mattam U, Kaminska D, Sotomayor-Rodriguez I, Rahman AP, Péterfy M, Pajukanta P, Pihlajamäki J, Chella Krishnan K. Hepatokine ITIH3 protects against hepatic steatosis[...]

A Leaky False Pouch: Left Ventricle Pseudoaneurysm with Active Hemopericardium Detected on Cardiac Computed Tomography Angiography

Barforoshi S, Shekar C, Yu Z, Liu E, Manubolu V, Budoff MJ, Roy SK. A Leaky False Pouch: Left Ventricle Pseudoaneurysm with Active Hemopericardium Detected[...]

Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study

Zheng J, Ambrosy AP, Bhatt AS, Collins SP, Flint KM, Fonarow GC, Fudim M, Greene SJ, Lala A, Testani JM, Varshney AS, Wi RSK, Sandhu[...]